We report a case of chikungunya fever, rarely seen by Japanese physicians. A 35-year-old Japanese man admitted September 12 for a 3-day fever had traveled to Flores island, Indonesia, July 14-Sep. 10. He had bilateral wrist arthralgia, mild bilateral finger swelling, and nonitching skin eruptions on the face, trunk, and both arms. The viral chikungunya genome was identified in serum on Sep. 12. Negative serum an-tichikungunya virus IgM antibodies on Sep. 12 became positive on Sep. 14, yielding the suspected diagnosis. Given the many Japanese visiting endemic chikungunya fever areas, Japanese physicians must learn to recognize such cases among travelers returning from such areas with fever, arthralgia, and skin eruptions.

Download full-text PDF

Source
http://dx.doi.org/10.11150/kansenshogakuzasshi.84.457DOI Listing

Publication Analysis

Top Keywords

chikungunya fever
12
flores island
8
japanese physicians
8
skin eruptions
8
japanese
5
fever
5
japanese patient
4
chikungunya
4
patient chikungunya
4
fever returning
4

Similar Publications

The Chikungunya virus (CHIKV) is a mosquito-borne virus with a long history of recurring epidemics transmitted through mosquitoes. The rapid spread of CHIKV has intensified the need for potent vaccines. Escherichia coli (), a vital part of human gut microbiota, is utilized in recombinant DNA technology for cloning.

View Article and Find Full Text PDF

Research progress of mosquito-borne virus mRNA vaccines.

Mol Ther Methods Clin Dev

March 2025

Beijing Institute of Tropical Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing Key Laboratory for Research on Prevention and Treatment of Tropical Diseases, Beijing, China.

In recent years, mRNA vaccines have emerged as a leading technology for preventing infectious diseases due to their rapid development and high immunogenicity. These vaccines encode viral antigens, which are translated into antigenic proteins within host cells, inducing both humoral and cellular immune responses. This review systematically examines the progress in mRNA vaccine research for major mosquito-borne viruses, including dengue virus, Zika virus, Japanese encephalitis virus, Chikungunya virus, yellow fever virus, Rift Valley fever virus, and Venezuelan equine encephalitis virus.

View Article and Find Full Text PDF

Background: Human activities, such as urbanization and climate change, have facilitated the spread of arbovirus-carrying vectors, disproportionately affecting vulnerable traditional Indigenous communities.

Objective: To explore the relationships between subclinical myocardial dysfunction, assessed by global longitudinal strain (GLS), and comprehensive arbovirus serology in an Indigenous population, while also describing the serological and epidemiological profile of dengue, chikungunya, and Zika viruses.

Methods: This ancillary study is part of the first phase (2016-2017) of the Project of Atherosclerosis among Indigenous Populations (PAI), a cross-sectional study involving participants from two Indigenous communities with different degrees of urbanization and a highly urbanized city in Northeast Brazil.

View Article and Find Full Text PDF

Background: Dengue, chikungunya, and Zika are mosquito-borne diseases of major human concern. Differential diagnosis is complicated in children and adolescents by their overlapping clinical features (signs, symptoms, and complete blood count results). Few studies have directly compared the three diseases.

View Article and Find Full Text PDF

The clinical profile and outcomes of children with chikungunya infection differ from those observed in adults. As there is a paucity of data on chikungunya infection in children, this study aimed to find the clinical course, complications, and mortality rates of chikungunya infection in children. This was a combined retrospective and prospective observational study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!